SCHEMBL16330764

SCHEMBL16330764

CNC(CC(C)C)C(=O)Nc1ncnc2c1c(C(N)=O)cn2[C@@H]1O[C@H](CO)C(O)[C@@H]1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.46
▸ STAT6 P42226 2/20 0.46
▸ HIF1A Q16665 2/20 0.46
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ADK P55263 5/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ GALR3 O60755 1/20 0.41
▸ S1PR4 O95977 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ S1PR1 P21453 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ PAX8 Q06710 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.40
▸ HSPA8 P11142 1/20 0.39
▸ TMEM97 Q5BJF2 2/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16330667 0.91 TP53 (0.55) TP53STAT6HIF1AADKALDH1A1
SCHEMBL16330686 0.89 HIF1A (0.47) TP53STAT6HIF1AMEN1KMT2A
SCHEMBL16330754 0.88 HIF1A (0.51) HIF1AMEN1KMT2AADKPAX8
SCHEMBL16330726 0.88 HIF1A (0.40) TP53STAT6HIF1AADKALDH1A1
SCHEMBL16330685 0.87 HIF1A (0.45) TP53STAT6HIF1AMEN1KMT2A
SCHEMBL16330762 0.83 HIF1A (0.48) TP53STAT6HIF1AMEN1KMT2A
SCHEMBL16330696 0.82 ADK (0.48) TP53STAT6HIF1AADK
SCHEMBL16330684 0.80 HIF1A (0.56) TP53STAT6HIF1AADKALDH1A1
SCHEMBL16330664 0.79 HIF1A (0.61) TP53STAT6HIF1AADKALDH1A1
SCHEMBL16330761 0.78 HIF1A (0.42) TP53STAT6HIF1AADKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS ENZON PHARMACEUTICALS, INC. (US) 2013-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS VEGFA, MKI67, PCNA TP53 282/4885STAT6 4220/4885HIF1A 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback